中医药联合免疫检测点抑制剂治疗非小细胞肺癌临床进展及展望Clinical Progress and Prospect of Traditional Chinese Medicine Combined with Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer
郭文韬
临床医学进展Vol.12 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.12121690, December 27 2022
PD-1抑制剂对非小细胞肺癌患者Mito+ T淋巴细胞免疫代谢影响模式Effect Model of PD-1 Inhibitors on Immune Metabolism of Mito+ T Lymphocytes in Patients with Non-Small Cell Lung Cancer
王 铮, 陈存海, 马学真
临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131145, January 31 2023
中药“扶正祛邪”以治疗非小细胞肺癌的药效初探Initially Exploring the Efficacy of the Traditional Chinese Medicine “Fuzheng Quxie” to Treat Non-Small Cell Lung Cancer
王文杰, 尹 楠, 申 越, 王 睿, 高 婧, 曹荣月 科研立项经费支持
中医学Vol.11 No.6, 全文下载: PDF HTML XML DOI:10.12677/TCM.2022.116154, November 4 2022
中医药在治疗晚期非小细胞肺癌中的作用及优势The Effects and Advantages of Traditional Chinese Medicine in Treatment of Advanced Non-Small Cell Lung Cancer
黄弦歌, 李和根 科研立项经费支持
中医学Vol.7 No.6, 全文下载: PDF HTML XML DOI:10.12677/TCM.2018.76058, November 9 2018
免疫治疗在非小细胞肺癌中的应用The Application of Immunotherapy in Non-Small Cell Lung Cancer
郭永欣, 姚 兵
临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141131, January 19 2024
驱动基因阴性晚期非小细胞肺癌免疫检查点抑制剂一线单药及联合化疗治疗进展Progress of Immune Checkpoint Inhibitors as First-Line Monotherapy and Combined Chemotherapy for Advanced Non-Small Cell Lung Cancer with Negative Driver Genes
张学文, 陈 杰, 郑凯曼, 姜 军
临床医学进展Vol.13 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1381815, August 17 2023